ChAdOx1-VZV

ChAdOx1-VZV · CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ChAdOx1-VZV, covering 2024-12-04 to 2024-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years [Phase 1]